AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2024 Earnings Call Transcript
Operator: Good morning and welcome to the AngioDynamics fiscal year 2024 Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode.
Angiodynamics Inc (ANGO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,793,454 | $10,850,397 | +42% | 0% |
| 2. | Renaissance Technologies Jim Simons | 1,097,614 | $6,640,565 | -4% | 0.01% |
| 3. | Royce & Associates Chuck Royce | 889,935 | $5,384,107 | +73% | 0.05% |
| 4. | Armistice Capital Steven Boyd | 836,000 | $5,057,800 | -5% | 0.06% |
| 5. | Kent Lake Capital Benjamin Natter | 750,000 | $4,537,500 | 2.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.70 | 10,000 | 539,066 | 2024-04-08 | Filing | ||
| $13.82 | 1,083 | Officer | 89,581 | 2022-10-12 | Filing | |
| $15.00 | 10,000 | Officer, Director | 450,407 | 2022-10-10 | Filing | |
| $22.64 | 1,000 | Officer | 76,081 | 2022-01-12 | Filing | |
| $22.84 | 10,000 | Officer, Director | 390,764 | 2022-01-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.95 | 4,633 | Officer | 19,189 | 2023-01-31 | Filing | |
| $22.44 | 5,000 | Officer | 23,822 | 2022-07-29 | Filing | |
| $22.44 | 3,513 | Officer | 22,874 | 2022-04-28 | Filing | |
| $23.26 | 1,299 | Director | 79,704 | 2022-04-12 | Filing | |
| $23.00 | 6,201 | Director | 80,003 | 2022-04-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,044,098 | $39,545,728 | 0% | |
| 2. | 2,268,461 | $17,784,734 | 0% | |
| 3. | 1,932,154 | $15,148,090 | 0.45% | |
| 4. | 1,886,200 | $14,787,815 | 0% | |
| 5. | 1,489,108 | $11,674,931 | 0% |
News See All
5 Micro-Cap Healthcare Stocks Insiders Are Buying
This article presents an overview of 5 Micro-Cap Healthcare Stocks Insiders Are Buying. For a detailed overview of such stocks read our article, 10 Micro-Cap Healthcare Stocks Insiders Are Buying...
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript
AngioDynamics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14. AngioDynamics, Inc.
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2024 Earnings Call Transcript
AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.09.
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2024 First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fourth Quarter and Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2023 Third Quarter Earnings Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2023 Second Quarter Earnings Call. At this time all participants are in listen-only-mode.
Where Do Hedge Funds Stand On AngioDynamics, Inc. (ANGO)?
We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC.
Should I Buy AngioDynamics, Inc. (ANGO)?
With the second-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the third ...
Billionaire Hedge Funds
